Product description

Adalimumab biosimilar, fully human monoclonal antibody to one of the major proinflammatory cytokines – tumor necrosis factor alpha (TNFα). Adalimumab is used in the treatment of rheumatoid arthritis, adult and pediatric Crohn’s disease, ulcerative colitis, ankylosing spondylitis, axial spondyloarthritis without radiographic evidence of ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, idiopathic juvenile arthritis. Approved in Russia in 2019. Phase III clinical studies also to be conducted in EU.
Read more

More products from BIOCAD

View all our products (9)

Products from other suppliers